PainNCT06684938
US Guided Sacroiliac Joint Injection
A study testing sacroiliac injection in people with Pain, run by Alexandria University at 2 sites in Egypt.
Trial summary
Sacroiliac joint (SIJ) pain is one of the underappreciated causes of low back pain. Recent studies have reported excellent outcomes after Ultrasound (US) guided SIJ injection with local anesthetics and corticosteroids, but these studies are characterized by wide variability in selection criteria and patient… Read more about this study
- Who is it for?
- Ages 20 to 80 years
- Conditions the study is for
- Pain
- What is being tested?
- sacroiliac injection
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 2 sitesEgypt
- Study dates
- 1 May 2023to 30 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- sacroiliac pain
Who cannot join
- -
Trial locations and contacts
2 sites in 1 country.
Egypt2 sites
Sherine El-Sherif
Alexandria, 21529
Alexandria University
Alexandria
About this study
Official title: Predictors of Outcome for Sacroiliac Joint Injection With Local Anaesthetic and Corticosteroids in Sacroiliac Joint Pain Patients
Sacroiliac joint (SIJ) pain is one of the underappreciated causes of low back pain. Recent studies have reported excellent outcomes after Ultrasound (US) guided SIJ injection with local anesthetics and corticosteroids, but these studies are characterized by wide variability in selection criteria and patient characteristics; therefore, there is a need to determine whether any demographic or clinical variables can be used to predict US-guided SIJ injection outcomes.
Read the detailed description
this study is testing the different predictors related to the patient that could affect his improvement by >50% after US guided SIJ injection with anaesthetic and steroids
- Conditions
- Pain
- Being tested
- sacroiliac injection
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
sacroiliac injectionDrug
sacroiliac injection with local anaesthetic and corticosteroids
| Study group | Role | What they receive |
|---|---|---|
| sacroiliac injection | Experimental | anaesthetic and steroid injection into the SIJ through US guidance Receives: Drug: sacroiliac injection |
What is being measured
The primary outcome is the main question the study is designed to answer.
postinjection sacroiliac pain intensity
using Visual analogue scale for pain
Measured: 3 months
postinjection disability questionnairre
using Modified Oswestry disability Questionnairre
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Nov 2024
- Study start1 May 2023
- Primary completion30 Nov 2024
- Study completion30 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sherine Elsherif, Alexandria University
- Investigators
- SHERINE EL-SHERIF, Principal investigator, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06684938
- Sponsor's protocol ID
- 0107462
- Status last verified
- Sep 2024
- First submitted
- 15 Oct 2024
- Last updated
- 18 Nov 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
El-Sherif S, Imam M, Hassan M, Elsharkawy M. Predictors of 3-month response to US-guided sacroiliac joint injection: a prospective study of diagnostic block-confirmed patients. Clin Rheumatol. 2026 Jul;45(7):4593-4600. doi: 10.1007/s10067-026-08167-y. Epub 2026 Jun 4.
PubMed 42243610
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predictors of Outcome for Sacroiliac Joint Injection With Local Anaesthetic and Corticosteroids in Sacroiliac Joint Pain Patients
- ClinicalTrials.gov ID
- NCT06684938
- Acronym / sponsor ID
- 0107462
- Conditions
- Pain
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Alexandria UniversityUniversity, hospital or other
- Study start
- 1 May 2023 (actual)
- Primary completion
- 30 Nov 2024 (actual)
- Study completion
- 30 Nov 2024 (actual)
- First posted
- 12 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sacroiliac joint (SIJ) pain is one of the underappreciated causes of low back pain. Recent studies have reported excellent outcomes after Ultrasound (US) guided SIJ injection with local anesthetics and corticosteroids, but these studies are characterized by wide variability in selection criteria and patient characteristics; therefore, there is a need to determine whether any demographic or clinical variables can be used to predict US-guided SIJ injection outcomes.
Detailed description
this study is testing the different predictors related to the patient that could affect his improvement by >50% after US guided SIJ injection with anaesthetic and steroids
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| sacroiliac injection | Experimental | Drug: sacroiliac injectionanaesthetic and steroid injection into the SIJ through US guidance |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- sacroiliac pain
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| sacroiliac injectionsacroiliac injection with local anaesthetic and corticosteroids | Drug | sacroiliac injection |
Primary outcome
postinjection sacroiliac pain intensity
Time frame: 3 months
using Visual analogue scale for pain
postinjection disability questionnairre
Time frame: 3 months
using Modified Oswestry disability Questionnairre
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2025.
- Derived from this study: PubMed 42243610El-Sherif S, Imam M, Hassan M, Elsharkawy M. Predictors of 3-month response to US-guided sacroiliac joint injection: a prospective study of diagnostic block-confirmed patients. Clin Rheumatol. 2026 Jul;45(7):4593-4600. doi: 10.1007/s10067-026-08167-y. Epub 2026 Jun 4.
Related trials for Pain
Not yet recruiting
Digital Use, 24-Hour Movement Behaviors, and Myofascial Release in University Students With Neck Pain
Forward Head Posture, Chronic Nonspecific Neck Pain
Recruiting
Effects of Virtual Reality Exergames Versus Spinal Manipulation in Chronic Nonspecific Low Back Pain
Chronic Nonspecific Low-back Pain, CNSLBP
Recruiting
Dietary Intervention for Migraine Relief
Migraine
RecruitingPhase 4
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
Laparoscopic Surgery, Visceral Pain, Postoperative
Not yet recruiting
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Adenomyosis, Adenomyoma of Uterus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
SHERINE EL-SHERIF principal investigator
Alexandria University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing sacroiliac injection in people with Pain, run by Alexandria University at 2 sites in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
postinjection sacroiliac pain intensity (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06684938, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.